000			02157nam a22002657a 4500
001			20241009114933.0
003			20241009114933.0
005			20241009115747.0
008			241009b |||||||| |||| 00| 0 eng d
020			_a 978-3-030-19018-7
020			_a978-3-030-19019-4
040			_cddc
041			_aEnglish
082			_a616.994 18 NAN
100			_qCristina Nanni
245			_a Molecular Imaging in Multiple Myeloma
260			_bSpringer Nature Switzerland AG | _c2019 _aPoliclinico S.Orsola-Malpighi Bologna Italy |
300			_a138 Pages
520			_aThis book provides a comprehensive overview of the importance of molecular imaging in multiple myeloma, with detailed explanation of its clinical impact. Other important features are the definition of criteria that will aid PET/CT interpretation; identification and explanation of the most frequent pitfalls; a brief overview of the advantages and limitations of DWI MR imaging, still an experimental technique in multiple myeloma; and examination of the possible role of emerging PET tracers. When appropriate, clinical cases are used to illustrate key teaching points. All physicians involved in oncological imaging should regularly reassess and update their routine practice in the evaluation of multiple myeloma patients. This is especially true now, given the recent clarification by the International Myeloma Working Group (IMWG) of the criteria for bone damage requiring therapy and the emerging data supporting the role of the newer functional imaging techniques in predicting outcome and/or evaluating response to therapy. In this challenging context, Molecular Imaging in Multiple Myeloma will be of high value for nuclear medicine physicians, radiologists, and hematologists.
600			_xHematology, Medical / Clinical Medicine, Medical / Hematology, Medical / Oncology / General, Medical / Radiology, Radiotherapy & Nuclear Medicine, Nuclear medicine, Oncology, Multiple myeloma -- Imaging -- Molecular aspects.
700			_qStefano Fanti
700			_q Lucia Zanoni
856			_uhttps://doi.org/10.1007/978-3-030-19019-4
942			_2ddc _cEB _n0
999			_c29092 _d29092